Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury

Transplantation Proceedings

Volumn 43, Issue 8, 2011, Pages 3000-3003

  Mazanowska, O ^a   Kaminska D ^a   Krajewska, M ^a   Zabinska M ^a   Kopec W ^a   Boratynska M ^a   Chudoba, P ^a   Patrzalek, D ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; FIBROSIS; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOPROTEASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 80054748790     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.08.012     Document Type: Conference Paper

References (18)

1. J.R. Chapman Clinical renal transplantation: where are we now, what are our key challenges? Transplant Proc 42 9 suppl 2010 S3
2. S. Hariharan, C.P. Johnson, and B.A. Bresnahan Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 2000 605
3. J.R. Chapman, P.J. O'Connell, and B.J. Nankivell Chronic renal allograft dysfunction J Am Soc Nephrol 16 2005 3015
4. J.R. Waller, and M.L. Nicholson Molecular mechanisms of renal allograft fibrosis Br J Surgery 88 2001 1429
5. W.H. Baricos Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation? Curr Opin Nephrol Hypertens 4 1995 365
6. G. Murphy, and F. Willenbrock Tissue inhibitors of metalloendopeptidases Methods Enzymol 248 1995 496
7. B. Lelongt, B. Legallicier, and R. Piedagnel Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens 10 2001 7
8. B. Bauvois Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-β1 in patients with distinct types of primary glomerulonephrits Nephrol Dial Transplant 22 2007 1115
9. T. Endo, K. Nakabayashi, and M. Sekiuchi Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blond of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining Clin Exp Nephrol 10 2006 253
10. H.-R. Chang, S.-F. Yang, and M.-L. Li Relationship between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease Clin Chim Acta 366 2006 243
11. M. Nagano, K. Fukami, and S. Yamagishi Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease Am J Nephrol 29 2009 109
12. M. Chromek, K. Tullus, and O. Hertting Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring Pediatr Res 53 2003 698
13. Z. Jiang, T. Sui, and B. Wang Relationships between MMP-2, MMP-9, TIMP-1, TIMP-2 levels and their pathogenesis in patients with lupus nephritis Rheumatol Int 30 2010 1219
14. K. Taranta-Janusz, W. Zoch-Zwierz, and A. Wasilewska Serum and urinary concentrations of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux (in polish) Pol Merk Lek 29 2010 88
15. A.A. Eddy, H. Kim, and J. Lopez-Guisa Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective Kidney Int 58 2000 618
16. J.H. Hörstrup, M. Gehrmann, and B. Schneider Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease Nephrol Dial Transplant 17 2002 1005
17. W. Wong, J. DeVito, and H. Nguyen Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine Am J Transplant 10 2010 2463
18. E. Rodrigo, M. López-Hoyos, and R. Escallada Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy Nephrol Dial Transplant 15 2000 2041